YI
111 IncNASDAQ
Healthcare • Medical Distribution
Updated 1 day ago
Coverage ready
Factor tilt: Anti-Value Micro Cap
$3.10-0.32%
Close Oct 13, 2026
- Market cap
- $27.35M
- 1 month
- -11.4%
- 3 months
- -26.2%
- 1 year
- -34.2%
- 52-week range
- $2.56$8.38
- Dividend
- No dividends on record
- Short interest
- 0.2% of float7K shares · settled Sep 30, 2026 · -34.7% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if YI is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: LOW
2 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Insider context
Sentiment: bearish
Last trade: sell 15 days ago
Red flags: 9
Largest 13-F holders · Q2 2026
8 filers reported a long position in YI for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Serenus Wealth Advisors, LLC | $358.7K | 4.3K | Unchanged |
| CITADEL ADVISORS LLC | $75.3K | 17.3K | New |
| RENAISSANCE TECHNOLOGIES LLC | $56K | 12.9K | -0.8% |
| UBS Group AG | $6.9K | 1.6K | +1,497% |
| SBI Securities Co., Ltd. | $647 | 149 | +3.5% |
| MORGAN STANLEY | $490 | 113 | Unchanged |
| JPMORGAN CHASE & CO | $194 | 47 | -9.6% |
| RHUMBLINE ADVISERS | $95 | 22 | Unchanged |
Get the Full Analysis for YI
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.